This high anticancer activity suggested that other factors in addition to NR4A1 might be involved, and we recently reported that DIM-3,5 analogs were NR4A1/NR4A2 ligands that bound both receptors and inhibited cancer cell growth [30]. Here, NR4A2 is linked to cancer.